Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Clinical trial NCT02221622 · COMPLETED
Trial details
- NCT number
- NCT02221622
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2018-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.